Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilant™ OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilant™ OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers – markers clinically validated to be associated with oral cancer – was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilant™ OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavirus, HPV-16). The BeVigilant™ OraFusion System is CE Marked and available in select markets outside of the United States. The BeVigilant™ OraFusion System is not available for sale in the U.S. Leadership: Bill Brodie, Chief Executive Officer Robert T. Hamilton, CPA, Chief Financial Officer Dragan Nebrigic, Ph.D., Chief Operating Officer Ben Beckham, Chief Commercial Officer Michael Donovan, M.D. Ph.D., Chief Clinical Officer
View Top Employees from Vigilant Biosciences, Inc.Website | http://www.vigilantbiosciences.com |
Revenue | $22 million |
Funding | $10.7 million |
Employees | 23 (15 on RocketReach) |
Founded | 2011 |
Address | 1008 Ranch Road 620 Suite 204, Lakeway, Texas 78734, US |
Phone | (954) 487-1740 |
Fax | (614) 652-7942 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Oncology, Health Care, Diagnostics, Medical Device |
Web Rank | 16 Million |
Keywords | Percentage Of Us Adults With Oral Cancer Exam, Test Oral Cancer Cd44 |
Competitors | Abionic, Banyan Biomarkers Inc (acquired by bioMerieux), Confirm Biosciences, Genomic Vision, ParaPRO, LLC |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Vigilant Biosciences, Inc. employee's phone or email?
The Vigilant Biosciences, Inc. annual revenue was $22 million in 2024.
Ben Beckham is the Chief Commercial Officer of Vigilant Biosciences, Inc..
15 people are employed at Vigilant Biosciences, Inc..
Vigilant Biosciences, Inc. is based in Lakeway, Texas.
The NAICS codes for Vigilant Biosciences, Inc. are [541714, 5417, 54171, 54, 541].
The SIC codes for Vigilant Biosciences, Inc. are [873, 87].